Browsing by author "Nomdedeu, Benet"

Repository

How to publish

Resources

FAQs

Now showing items 1-8 of 8

Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome

Córdoba, Iris; González-Porras, José R.; Nomdedeu, Benet; Luño Fernández, Elisa; Paz, Raquel de (American Cancer Society, 2012)
Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome

Sánchez Castro, Judith; Marco Betés, Víctor; Gómez Arbonés, Xavier; Arenillas, Leonor; Valcárcel Ferreiras, David; Vallespí, Teresa; Nomdedeu, Benet; Luño Fernández, Elisa (Elsevier, 2013-04)
Cytogenetic risk stratification in chronic myelomonocytic leukemia

Such, Esperanza; Cervera, José; Costa, Dolors; Solé Ristol, Francesc; Vallespí, Teresa; Luño Fernández, Elisa; Collado, Rosa; Calasanz, María José; Hernández Rivas, Jesús María; Cigudosa, Juan C.; Nomdedeu, Benet; Mallo, Mar; Carbonell, Félix; Bueno, Javier; Ardanaz, María Teresa (2011)
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

Such, Esperanza; Germing, Ulrich; Malcovati, Luca; Cervera Zamora, José Vicente; Kuendgen, Andrea; Della Porta, Matteo G.; Nomdedeu, Benet; Arenillas, Leonor; Luño Fernández, Elisa (2013)
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish Registry

Bernal del Castillo, Teresa; Martínez Camblor, Pablo; Sánchez García, Joaquín; Paz, Raquel de; Luño Fernández, Elisa; Nomdedeu, Benet; Ardanaz, María Teresa; Pedro, Carme; Amigo, M. L.; Xicoy, Blanca (Nature Publishing Group, 2015)
Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion

Sánchez García, Joaquín; Cañizo, Consuelo del; Lorenzo, Ignacio; Nomdedeu, Benet; Luño Fernández, Elisa (Wiley, 2014)
Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis

Rojas, Silvia; Díez Campelo, María; Luño Fernández, Elisa; Cabreo, Mónica; Pedro, Carme; Calabuig, Marisa; Nomdedeu, Benet; Cedena, María Teresa; Arrizabalaga, Beatriz; García, Marta (Elsevier, 2014)
Use of newer prognostic indices for patients with myelodysplastic syndromes in the low

Valcárcel Ferreiras, David; Sanz, Guillermo; Ortega, Margarita; Nomdedeu, Benet; Luño Fernández, Elisa; Díez Campelo, María; Ardanaz, María Teresa; Pedro, Carme; Montoro, Julia; Collado, Rosa; Andreu, Rafael; Marco, Víctor; Cedena, María Teresa; Tormo, Mar; Brunet, Salut; Muñoz, Juan Antonio; Gómez, Valle; Bailén, Alicia; Sánchez García, Joaquín; Merchán, Brayan; Cañizo, Consuelo del; Vallespí, Teresa; Bargay, Joan; González, Bernardo; Xicoy, Blanca (Elsevier, 2015)

Browsing by author "Nomdedeu, Benet"

Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome ﻿

Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome ﻿

Cytogenetic risk stratification in chronic myelomonocytic leukemia ﻿

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia ﻿

Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish Registry ﻿

Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion ﻿

Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis ﻿

Use of newer prognostic indices for patients with myelodysplastic syndromes in the low ﻿

Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome

Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome

Cytogenetic risk stratification in chronic myelomonocytic leukemia

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish Registry

Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion

Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis

Use of newer prognostic indices for patients with myelodysplastic syndromes in the low